Kane Biotech Management

Management criteria checks 2/4

Kane Biotech's CEO is Marc Edwards, appointed in Sep 2018, has a tenure of 5.58 years. total yearly compensation is CA$406.83K, comprised of 61.5% salary and 38.5% bonuses, including company stock and options. directly owns 4.47% of the company’s shares, worth CA$794.90K. The average tenure of the management team and the board of directors is 4.1 years and 5.6 years respectively.

Key information

Marc Edwards

Chief executive officer

CA$406.8k

Total compensation

CEO salary percentage61.5%
CEO tenure5.6yrs
CEO ownership4.5%
Management average tenure4.1yrs
Board average tenure5.6yrs

Recent management updates

Recent updates

Here's Why Kane Biotech (CVE:KNE) Can Afford Some Debt

Nov 05
Here's Why Kane Biotech (CVE:KNE) Can Afford Some Debt

Is Kane Biotech (CVE:KNE) A Risky Investment?

Jul 14
Is Kane Biotech (CVE:KNE) A Risky Investment?

Is Kane Biotech (CVE:KNE) A Risky Investment?

Mar 27
Is Kane Biotech (CVE:KNE) A Risky Investment?

CEO Compensation Analysis

How has Marc Edwards's remuneration changed compared to Kane Biotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023CA$407kCA$250k

-CA$5m

Sep 30 2023n/an/a

-CA$4m

Jun 30 2023n/an/a

-CA$4m

Mar 31 2023n/an/a

-CA$4m

Dec 31 2022CA$303kCA$242k

-CA$4m

Sep 30 2022n/an/a

-CA$4m

Jun 30 2022n/an/a

-CA$5m

Mar 31 2022n/an/a

-CA$5m

Dec 31 2021CA$329kCA$225k

-CA$5m

Sep 30 2021n/an/a

-CA$4m

Jun 30 2021n/an/a

-CA$4m

Mar 31 2021n/an/a

-CA$3m

Dec 31 2020CA$353kCA$225k

-CA$4m

Sep 30 2020n/an/a

-CA$4m

Jun 30 2020n/an/a

-CA$4m

Mar 31 2020n/an/a

-CA$2m

Dec 31 2019CA$311kCA$225k

-CA$960k

Sep 30 2019n/an/a

-CA$510k

Jun 30 2019n/an/a

-CA$685k

Mar 31 2019n/an/a

-CA$3m

Dec 31 2018CA$85kCA$67k

-CA$3m

Sep 30 2018n/an/a

-CA$4m

Jun 30 2018n/an/a

-CA$4m

Mar 31 2018n/an/a

-CA$4m

Dec 31 2017CA$18kn/a

-CA$3m

Compensation vs Market: Marc's total compensation ($USD295.88K) is above average for companies of similar size in the Canadian market ($USD174.32K).

Compensation vs Earnings: Marc's compensation has increased whilst the company is unprofitable.


CEO

Marc Edwards

5.6yrs

Tenure

CA$406,832

Compensation

Mr. Marc Edwards is the Founder and President of VetRx, a Montreal-based technology company specializing in daollection, cleansing, marketing and pharmaceutical compliance for the veterinary industry. Mr....


Leadership Team

NamePositionTenureCompensationOwnership
Marc Edwards
President5.6yrsCA$406.83k4.47%
CA$ 794.9k
Ray Dupuis
Chief Financial Officer6.6yrsCA$231.39k0.75%
CA$ 133.0k
Kevin Cole
President & CEO of STEM Animal Health Inc3.5yrsCA$432.52kno data
Dena Mehraban
General Manager of STEM Animal Health Incless than a yearCA$256.16kno data
Robert Huizinga
Executive Chairman & Member of Scientific Advisory Board5.6yrsno datano data
Gregory Schultz
Chief Scientific Officer & Member of Scientific Advisory Board2yrsno datano data
Lorne Gorber
Investor Relationsno datano datano data
Lori Christofalos
Vice President of Quality & Compliance4.7yrsno datano data
Wendy Nachtigall
Director of Marketingno datano datano data
Nicole Sendey
Investor Relations Adviserno datano datano data
Mark Ahrens-Townsend
Advisorno dataCA$244.05kno data

4.1yrs

Average Tenure

Experienced Management: KNE's management team is considered experienced (4.1 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Marc Edwards
President8.2yrsCA$406.83k4.47%
CA$ 794.9k
Robert Huizinga
Executive Chairman & Member of Scientific Advisory Board5.6yrsno datano data
Gregory Schultz
Chief Scientific Officer & Member of Scientific Advisory Board2.3yrsno datano data
Georges Morin
Independent Director3.9yrsCA$41.53k0.11%
CA$ 20.2k
Philip Renaud
Vice Chairman13.6yrsCA$44.73k20.77%
CA$ 3.7m
Rashieda Gluck
Member of Scientific Advisory Board5.6yrsCA$13.30kno data
Gordon Guay
Chairman of Scientific Advisory Board5.6yrsno datano data
John Coleman
Directorless than a yearCA$2.25kno data

5.6yrs

Average Tenure

Experienced Board: KNE's board of directors are considered experienced (5.6 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.